Message Testing in Older Adult Smokers

January 5, 2024 updated by: University of Wisconsin, Madison

Message Testing in Older Adult Smokers (MCAS-2)

This study is examining different messages to motivate older smokers to quit smoking. Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia. Participants can expect to take part in a one-time 30 minute online survey.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

820

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Madison, Wisconsin, United States, 53705
        • University of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Current smoker (smoking at least some days per week)
  • Ability to read and write English
  • Between the ages of 50 and 80 years old

Exclusion Criteria:

  • History of Mild Cognitive Impairment or dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Hope message
Participants will view a hope-based video message and flyer.
Participants will view a flyer and video
Active Comparator: Fear message
Participants will view a fear-based video message and flyer.
Participants will view a flyer and video
Placebo Comparator: Control message
Participants will view a water advertisement video and flyer.
Participants will view a flyer and video

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotional Response
Time Frame: Through study completion, approximately 30 minutes
Measure participants' emotional response to the messages using a 1-9 scaled measurement of 14 different emotions (9 indicating more emotional response). Emotionality will be presented together summarizing the mean presentation of these emotions by the different groups.
Through study completion, approximately 30 minutes
Motivation to Quit
Time Frame: Through study completion, approximately 30 minutes
Measure participants' motivation to quit after viewing the flyer and video, using a 1 item scaled measurement of motivation to quit (1-7 scale, 7 indicating higher motivation).
Through study completion, approximately 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adrienne Johnson, PhD, University of Wisconsin, Madison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2022

Primary Completion (Actual)

July 18, 2022

Study Completion (Actual)

July 18, 2022

Study Registration Dates

First Submitted

July 20, 2022

First Submitted That Met QC Criteria

July 21, 2022

First Posted (Actual)

July 22, 2022

Study Record Updates

Last Update Posted (Estimated)

January 31, 2024

Last Update Submitted That Met QC Criteria

January 5, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-0624 (Other Identifier: UW Madison)
  • A534253 (Other Identifier: UW- Madison)
  • SMPH/MEDICINE/GEN INT MD (Other Identifier: UW Madison)
  • 1K23AG067929-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on Flyer and video

Subscribe